February 4, 2019
Yearly Archives: 2019
February 4, 2019
Benjamin E. Haithcock, MD, Thoracic Oncology, Surgical Oncology
February 4, 2019
Benjamin Calvo, MD, Gastrointestinal Program, Surgical Oncology
February 4, 2019
Autumn McRee, MD, Gastrointestinal Oncology
February 4, 2019
Angela Smith, MD, Urologic Oncology
February 4, 2019
Andrew Wang, MD, Gastrointestinal and Urologic oncology programs, Radiation Oncology
February 4, 2019
Albert Baldwin, PhD, Associate Director, Basic Research
February 2, 2019
Der to receive mentorship award from Carolina
Channing Der, PhD, a member of the University of North Carolina Lineberger Comprehensive Cancer Center and the Sarah Graham Kenan Distinguished Professor of Pharmacology, will receive the “Mentor Award for Lifetime Achievement” at an awards banquet April 8. Der is one of 24 faculty members and teaching assistants who have been named winners of Carolina’s …
January 31, 2019
Scientists uncover mechanism cells use to deactivate a signal that’s hyperactive in cancer
University of North Carolina Lineberger Comprehensive Cancer Center researchers and collaborators have discovered how a cellular signal that’s abnormally hyperactive in cancer can be deactivated. In the journal Cell Reports, UNC Lineberger’s M. Ben Major, PhD, and colleagues published a paper on how the WNT signaling pathway is regulated. WNT proteins increase tumor onset, growth …
January 30, 2019
Stand Up To Cancer names UNC Lineberger researchers to ‘Dream Team’
The multi-institutional team, which is co-led by UNC Lineberger's Gianpietro Dotti, MD, and includes six UNC Lineberger researchers, will focus on developing chimeric antigen receptor T-cell (CAR-T) therapies to recognize and attack T-cell lymphoma, a group of rare cancers of the blood and immune system.